Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01977027 · ClinicalTrials.gov registry record · NA
Strategies for Recovery of Dexterity Post Stroke
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 91
- Enrollment target
NCT01977027: Clinical Trial NA study, sponsored by NYU Langone Health.
NCT01977027 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01977027, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
Study Summary
Motor learning can be affected by the sensory difficulties that may be experienced as a result of a stroke. This study will help us better understand what kinds of sensory information can help with the re-learning of grasping with the affected hand despite the sensory difficulties produced by the stroke.
Primary Outcome
5 experiments will be performed over 7 visits to examine the best approach to retrain adaptation.
Interventions
- OTHER Alternate Hand Training or Affected Hand Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2013-08 |
| Est. Completion | 2019-05-10 |
| Phase | NA |
Why NCT01977027 stopped before completion
NCT01977027 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Alternate Hand Training or Affected Hand Training is the first listed.
NCT01977027 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01977027 about?
NCT01977027 is a clinical study titled "Strategies for Recovery of Dexterity Post Stroke". Motor learning can be affected by the sensory difficulties that may be experienced as a result of a stroke. This study will help us better understand what kinds of sensory information can help with the re-learning of grasping with the affected hand despite the sensory difficulties produced by the st...
What is the current status of trial NCT01977027?
This trial is currently terminated. It is a NA study. The enrollment target is 91 participants. The study started on 2013-08. Estimated completion is 2019-05-10.
What interventions are being tested in trial NCT01977027?
The interventions under investigation include: Alternate Hand Training or Affected Hand Training (OTHER).
Who is sponsoring clinical trial NCT01977027?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01977027's enrollment target sits among peer trials
91 939th of 2000 higher than 1,060 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia